Mereo BioPharma Group PLC (MREO)
3.11
-0.04
(-1.27%)
USD |
NASDAQ |
May 02, 16:00
3.16
+0.05
(+1.61%)
Pre-Market: 08:47
Mereo BioPharma Group 1 Year Total Returns (Daily): 159.2% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | 159.2% |
May 01, 2024 | 156.1% |
April 30, 2024 | 132.8% |
April 29, 2024 | 110.7% |
April 26, 2024 | 122.8% |
April 25, 2024 | 150.9% |
April 24, 2024 | 167.3% |
April 23, 2024 | 180.8% |
April 22, 2024 | 181.8% |
April 19, 2024 | 146.7% |
April 18, 2024 | 136.6% |
April 17, 2024 | 148.1% |
April 16, 2024 | 156.2% |
April 15, 2024 | 154.3% |
April 12, 2024 | 177.4% |
April 11, 2024 | 191.5% |
April 10, 2024 | 225.9% |
April 09, 2024 | 252.4% |
April 08, 2024 | 256.9% |
April 05, 2024 | 296.4% |
April 04, 2024 | 309.5% |
April 03, 2024 | 333.4% |
April 02, 2024 | 378.1% |
April 01, 2024 | 382.4% |
March 28, 2024 | 335.5% |
Date | Value |
---|---|
March 27, 2024 | 280.8% |
March 26, 2024 | 274.1% |
March 25, 2024 | 276.7% |
March 22, 2024 | 252.7% |
March 21, 2024 | 242.2% |
March 20, 2024 | 318.9% |
March 19, 2024 | 305.3% |
March 18, 2024 | 312.0% |
March 15, 2024 | 265.9% |
March 14, 2024 | 258.3% |
March 13, 2024 | 269.2% |
March 12, 2024 | 348.7% |
March 11, 2024 | 355.1% |
March 08, 2024 | 321.2% |
March 07, 2024 | 315.7% |
March 06, 2024 | 314.9% |
March 05, 2024 | 296.2% |
March 04, 2024 | 308.9% |
March 01, 2024 | 356.3% |
February 29, 2024 | 325.8% |
February 28, 2024 | 318.0% |
February 27, 2024 | 331.3% |
February 26, 2024 | 305.8% |
February 23, 2024 | 291.5% |
February 22, 2024 | 258.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.91%
Minimum
May 11 2022
395.1%
Maximum
Mar 18 2021
30.86%
Average
-7.90%
Median
Aug 26 2021
1 Year Total Returns (Daily) Benchmarks
Adaptimmune Therapeutics PLC | -13.14% |
Biodexa Pharmaceuticals Plc | -92.30% |
NuCana PLC | -79.67% |
TC BioPharm (Holdings) PLC | -93.16% |
Autolus Therapeutics PLC | 109.7% |